Retrospective analysis of first-line anti-vascular endothelial growth factor treatment patterns in wet age-related macular degeneration. [electronic resource]
- Advances in therapy Dec 2013
- 1111-27 p. digital
Publication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't
1865-8652
10.1007/s12325-013-0078-4 doi
Age Factors Aged Aged, 80 and over Antibodies, Monoclonal, Humanized--administration & dosage Cohort Studies Cost-Benefit Analysis Databases, Factual Dose-Response Relationship, Drug Drug Administration Schedule Female Follow-Up Studies Health Care Costs Humans Intravitreal Injections Linear Models Male Middle Aged Multivariate Analysis Poisson Distribution Ranibizumab Receptors, Vascular Endothelial Growth Factor--administration & dosage Recombinant Fusion Proteins--administration & dosage Retrospective Studies Risk Assessment Severity of Illness Index Sex Factors Time Factors Treatment Outcome United States Vascular Endothelial Growth Factor A--administration & dosage Wet Macular Degeneration--diagnosis